| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Institut für Biochemie, Rheinisch-Westfälische Technische Hochschule Aachen, Aachen, Germany; and
Diaclone, Besançon, France
Soluble receptors for several cytokines have been detected
in body fluids and are believed to modulate the cytokine response by
binding the ligand and thereby reducing its bioavailability. In the
case of IL-6, the situation is more complex. The receptor consists of
two components, including a ligand-binding 
-subunit (IL-6R, gp80, or
CD126), which in its soluble (s) form (sIL-6R) acts agonistically by
making the ligand accessible to the second subunit, the signal
transducer gp130 (CD130). Soluble forms of both receptor subunits are
present in human blood. Gel filtration of iodinated IL-6 that had been
incubated with human serum revealed that IL-6 is partially trapped in
IL-6/sIL-6R/sgp130 ternary complexes. sgp130 from human plasma was
enriched by immunoaffinity chromatography and identified as a 100-kDa
protein. Functionally equivalent rsgp130 was produced in
baculovirus-infected insect cells to study its antagonistic potential
on four different cell types. It was found that in situations in which
cells lacking membrane-bound IL-6R were stimulated with IL-6/sIL-6R
complexes, sgp130 was a much more potent antagonist than it was
on IL-6R-positive cells stimulated with IL-6 alone. In the latter case,
the neutralizing activity of sgp130 could be markedly enhanced by
addition of sIL-6R. As a consequence of these findings, sIL-6R of human
plasma must be regarded as an antagonistic molecule that enhances the
inhibitory activity of sgp130. Furthermore, in combination with sIL-6R,
sgp130 is a promising candidate for the development of IL-6
antagonists.
This article has been cited by other articles:
|
|
 |
|
  L. Chen, A. Frister, S. Wang, A. Ludwig, H. Behr, S. Pippig, B. Li, A. Simm, B. Hofmann, C. Pilowski, et al. Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H987 - H996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Fitzgerald, T. G. Poehlmann, E. Schleussner, and U. R. Markert Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3) Hum. Reprod. Update, April 17, 2008; (2008) dmn010v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Metz, M. Wiesinger, M. Vogt, H. Lauks, G. Schmalzing, P. C. Heinrich, and G. Muller-Newen Characterization of the Interleukin (IL)-6 Inhibitor IL-6-RFP: FUSED RECEPTOR DOMAINS ACT AS HIGH AFFINITY CYTOKINE-BINDING PROTEINS J. Biol. Chem., January 12, 2007; 282(2): 1238 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Memoli, G. Grandaliano, M. Soccio, L. Postiglione, B. Guida, V. Bisesti, P. Esposito, A. Procino, D. Marrone, A. Michael, et al. In Vivo Modulation of Soluble "Antagonistic" IL-6 Receptor Synthesis and Release in ESRD J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1099 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ferrucci, A. Corsi, F. Lauretani, S. Bandinelli, B. Bartali, D. D. Taub, J. M. Guralnik, and D. L. Longo The origins of age-related proinflammatory state Blood, March 15, 2005; 105(6): 2294 - 2299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Classen-Linke, G. Muller-Newen, P.C. Heinrich, H.M. Beier, and U. von Rango The cytokine receptor gp130 and its soluble form are under hormonal control in human endometrium and decidua Mol. Hum. Reprod., July 1, 2004; 10(7): 495 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Cui, F. N. Rouhani, F. Hawari, and S. J. Levine An Aminopeptidase, ARTS-1, Is Required for Interleukin-6 Receptor Shedding J. Biol. Chem., August 1, 2003; 278(31): 28677 - 28685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ancey, A. Kuster, S. Haan, A. Herrmann, P. C. Heinrich, and G. Muller-Newen A Fusion Protein of the gp130 and Interleukin-6Ralpha Ligand-binding Domains Acts as a Potent Interleukin-6 Inhibitor J. Biol. Chem., May 2, 2003; 278(19): 16968 - 16972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Von der Thusen, J. Kuiper, T. J. C. Van Berkel, and E. A. L. Biessen Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential Pharmacol. Rev., March 1, 2003; 55(1): 133 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Y. PARK, R. B. GOODMAN, K. P. STEINBERG, J. T. RUZINSKI, F. RADELLA II, D. R. PARK, J. PUGIN, S. J. SKERRETT, L. D. HUDSON, and T. R. MARTIN Cytokine Balance in the Lungs of Patients with Acute Respiratory Distress Syndrome Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1896 - 1903. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Audet, C. L. Miller, S. Rose-John, J. M. Piret, and C. J. Eaves Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells PNAS, February 13, 2001; 98(4): 1757 - 1762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. JONES, S. HORIUCHI, N. TOPLEY, N. YAMAMOTO, and G. M. FULLER The soluble interleukin 6 receptor: mechanisms of production and implications in disease FASEB J, January 1, 2001; 15(1): 43 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K L STREETZ, T LUEDDE, M P MANNS, and C TRAUTWEIN Interleukin 6 and liver regeneration Gut, August 1, 2000; 47(2): 309 - 312. [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Clark, L. G. Rinker, N. S. Lessov, K. Hazel, J. K. Hill, M. Stenzel-Poore, F. Eckenstein, and E. C. Haley Jr Lack of Interleukin-6 Expression Is Not Protective Against Focal Central Nervous System Ischemia Editorial Comment Stroke, July 1, 2000; 31(7): 1715 - 1720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Auernhammer and S. Melmed Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function Endocr. Rev., June 1, 2000; 21(3): 313 - 345. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Sammons, N. Ahmed, M.A. Khokher, and H.T. Hassan Mechanisms Mediating the Inhibitory Effect of All-Trans Retinoic Acid on Primitive Hematopoietic Stem Cells in Human Long-Term Bone Marrow Culture Stem Cells, May 1, 2000; 18(3): 214 - 219. [Abstract] [Full Text]
|
|
|
|
 |
|
 I. Kurth, U. Horsten, S. Pflanz, A. Timmermann, A. Kuster, H. Dahmen, I. Tacken, P. C. Heinrich, and G. Muller-Newen Importance of the Membrane-Proximal Extracellular Domains for Activation of the Signal Transducer Glycoprotein 130 J. Immunol., January 1, 2000; 164(1): 273 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Le Meur, V. Lorgeot, J.-C. Aldigier, J. Wijdenes, C. Leroux-Robert, and V. Praloran Whole blood production of monocytic cytokines (IL-1{beta}, IL-6, TNF-{alpha}, sIL-6R, IL-1Ra) in haemodialysed patients Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2420 - 2426. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
